NDC 71335-2635 – Ondansetron

Ondansetron 8 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC71335-2635

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA078152
Marketed since
June 27, 2007
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (10)

Package NDCDescriptionSince
71335-2635-03 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-0)Jun 2, 2025
71335-2635-130 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-1)Jun 2, 2025
71335-2635-210 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-2)Jun 2, 2025
71335-2635-35 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-3)Jun 2, 2025
71335-2635-44 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-4)Jun 2, 2025
71335-2635-56 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-5)Jun 2, 2025
71335-2635-614 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-6)Jun 2, 2025
71335-2635-760 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-7)Jun 2, 2025
71335-2635-812 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-8)Jun 2, 2025
71335-2635-990 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-9)Jun 2, 2025

Other Ondansetron products